Lambert, Peter A - Aston University - School of Life & Health Sciences, Biology/Biosciences

个人简介

2011-date Professor of Microbial Chemistry, Aston University 2005-2011 Professor of Microbiology, Aston University 1998-2005 Reader in Microbiology, Aston University 1990-98 Senior Lecturer in Microbiology, Aston University 1990 DSc., Loughborough University 1980-90 Lecturer in Microbiology, Aston University 1977-80 Section Head, Microbial Biochemistry, Glaxo Group Research, Greenford 1974-77 Research Fellow, University of Newcastle upon Tyne (with Sir James Baddiley) 1970-74 PhD., CNAA, London 1966-70 BSc., Chemistry, Loughborough University 1966-70 Diploma of Industrial Studies, Loughborough University

研究领域

Infectious diseases, their diagnosis and treatment Molecular typing and epidemiology of infectious diseases Microbial pathogenicity, virulence factors, adhesion and colonisation, resistance to host defences Antibiotics, mechanisms of action and resistance Structure, function, properties and biosynthesis of microbial cell walls and membranes

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Genotypic and Antimicrobial Characterisation of Propionibacterium acnes Isolates from Surgically Excised Lumbar Disc Herniations. Rollason J, McDowell A, Albert HB, Barnard E, Worthington T, Hilton AC, Vernallis A, Patrick S, Elliott T, Lambert P. Biomed Res Int. 2013;2013:530382. Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae? Albert HB, Lambert P, Rollason J, Sorensen JS, Worthington T, Pedersen MB, N?rgaard HS, Vernallis A, Busch F, Manniche C, Elliott T. Eur Spine J. 2013 22(4):690-6. Answer to the Letter to the Editor of Zafar Ahmad et al. concerning "Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized controlled trial of efficacy" by Albert HB et al., Eur Spine J (2013) 22:697-707. Lambert P, Albert HB. Eur Spine J. 2013 Oct;22(10):2346-7. The N-Terminus of CD14 Acts to Bind Apoptotic Cells and Confers Rapid-Tethering Capabilities on Non-Myeloid Cells. Thomas L, Bielemeier A, Lambert PA, Darveau RP, Marshall LJ, Devitt A. PLoS One. 2013 8(7):e70691. Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections. Daneshpour N, Collighan R, Perrie Y, Lambert P, Rathbone D, Lowry D, Griffin M. Eur J Pharm Biopharm. 2012 S0939-6411. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Karpanen TJ, Casey AL, Lambert PA, Cookson BD, Nightingale P, Miruszenko L, Elliott TS. Infect Control Hosp Epidemiol. 2012 33 3-9. Lecture Notes: Medical Microbiology and Infection. Tom Elliott, Anna Casey, Peter Lambert, Jonathan Sandoe. 2011 John Wiley & Sons, ISBN-10: 1-4443-3465-4. Propionibacterium acnes: infection beyond the skin. Perry A, Lambert PA. Expert Rev Anti Infect Ther. 2011 9 1149-56. A comparative study to evaluate surface microbial contamination associated with copper-containing and stainless steel pens used by nurses in the critical care unit. Casey AL, Karpanen TJ, Adams D, Lambert PA, Nightingale P, Miruszenko L, Elliott TS. Am J Infect Control. 2011 39 52-4. Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing. Karpanen TJ, Casey AL, Conway BR, Lambert PA, Elliott TS. J Antimicrob Chemother. 2011 66 1777-84. A Novel Multilocus Sequence Typing Scheme for the Opportunistic Pathogen Propionibacterium acnes and Characterisation of Type I Cell Surface-Associated Antigens. McDowell A, Gao A, Barnard E, Fink C, Murray PI, Dowson CG, Nagy I, Lambert PA, Patrick S. Microbiology. 2011 157 1990-2003. Genetic characterisation of clinical isolates of Clostridium difficile using an optimised RAPD protocol and PCR ribotyping reveals strain diversity between two tertiary referral Trusts in the West Midlands, UK. Green LM, Worthington T, Hilton AC, Lambert PA. J Med Microbiol. 2011 60 1287-91. Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores. Wheeldon L, Worthington T, Lambert P. J Appl Microbiol. 2011 Jan 24 PMID: 21261795. Proteomic analysis of the anti-inflammatory action of minocycline. Dunston CR, Griffiths HR, Lambert PA, Staddon S, Vernallis AB. Proteomics. 2011 11 42-51. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I. Int J Infect Dis. 2011 15 131-5. Enhanced chlorhexidine skin penetration with eucalyptus oil. Karpanen TJ, Conway BR, Worthington T, Hilton AC, Elliott TS, Lambert PA. BMC Infect Dis. 2010 10 278. Peptidoglycan derived from S. epidermidis induces Connexin43 hemichannel activity with consequences on the innate immune response in endothelial cells. Robertson J, Lang S, Lambert PA, Martin PE. Biochem J. 2010 432 133-43. Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision. Worthington T, Dunlop D, Casey A, Lambert P, Luscombe J, Elliott T. Br J Biomed Sci. 2010 67 71-6. Phenotypic characterisation of Clostridium difficile reveals lack of extracellular virulence factor production and significant differences in antibiogram profiles. Green LM, Worthington T, Hilton AC, Lambert PA. Int J Antimicrob Agents. 2010 35 305-6. Casey AL, Adams D, Karpanen TJ, Lambert PA, Cookson BD, Nightingale P, Miruszenko L, Shillam R, Christian P, Elliott TS. Role of copper in reducing hospital environment contamination. J Hosp Infect. 2010 74 72-7.